MDXG Q3 2017 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$85M+31.3% YoY

Gross Profit

$75M88.7% margin

Operating Income

$9M10.5% margin

Net Income

$17M20.6% margin

EPS (Diluted)

$0.15

QoQ Revenue Growth

+10.7%

Cash Flow

Operating Cash Flow

$18M

Free Cash Flow

$17M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$179M

Total Liabilities

$36M

Stockholders' Equity

$142M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$85M	$64M	+31.3%
Gross Profit	$75M	$56M	+32.9%
Operating Income	$9M	$5M	+88.0%
Net Income	$17M	$3M	+425.7%